(Health-NewsWire.Net, December 01, 2017 ) According to the report Europe Proteomics Market, published by Market Data Forecast, the market is expected to grow at a CAGR of 11.2% and reach USD 5.12 billion in 2021 from USD 3.01 billion in 2016.
Proteomics is the study of the structure and functions of proteins that can be used in the drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to other with time.
Proteomics is used to evaluate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. In addition, it finds extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis, which has led to the stellar growth of the proteomics market in the past few years. With the increase in awareness regarding the benefits of personalized medicines, companies and government organizations have increased their R&D expenditure on the development of proteomics. As per the proteomics market research report, it is estimated that reagents segment will continue to lead the overall market during the forecast period.
Personalized medicine is a new and better approach to healthcare based on each person's unique genetic makeup. In personalized medicine, diagnostic testing is often employed to select appropriate and optimal therapies based on the context of a patients genetic content or other molecular & cellular analysis. Personalized medicine finds extensive applications in the diagnosis and treatment of cancer. Proteomics is an emerging field that can make unique contributions to the field of personalized medicines.
Get a comprehensive overview of the Europe Proteomics Market: http://www.marketdataforecast.com/market-reports/europe-proteomics-market-1996/
Europe Proteomics Market: Drivers & Restraints Increasing requirement for customized medicine, R&D use, technological advancements, and increased financing for proteomics ventures are some of the factors driving the market. However, decreasing funds in key markets, sequestration cuts in the U.S. and decreased assets for proteomics research, high cost of instruments and hardware, and lack of talented scientists are some of the major factors restraining the market.
Get accurate market forecast and analysis on the Europe Proteomics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/europe-proteomics-market-1996/request-sample
Proteomics Market: Segmentation By Instrument o Protein Microarrays Biochips o Protein Chips o Lab-on Chips Microarray instruments o Integrated Systems o Arrayers o Microarray Scanners o Spectroscopy Mass Spectrometry and CD Spectroscopy NMR Spectroscopy CD Spectroscopy o X-ray crystallography o Chromatography HPLC Ion Chromatography Affinity Chromatography Supercritical Fluid Chromatography o Electrophoresis Gel electrophoresis Capillary electrophoresis o Surface Plasmon Resonance o Protein fractionation By Reagent o Protein Microarray Reagents o X-Ray Crystallography Reagents o Spectroscopy Reagents o Chromatography Reagents o Electrophoresis Reagents o Immunoassay Reagents o Protein Fractionation Reagent By Service & Software o Analytical Laboratory Services Protein Identification Protein Separation Protein Sequencing o Data Analysis & Maintenance Bioinformatics Databases, Bioinformatics Tools o Quantitation Services By Application o Diagnostics o Drug Discovery o other proteomic Application
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-proteomics-market-1996/customize-report
Europe Proteomics Market: Overview Proteomics is the study of the structure and functions of proteins that can be used in the drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to other with time. Large number of organizations invest in the R&D of proteomics to understand the metabolic pathway involved in the progression of disease and the development of novel molecules for its treatment and diagnosis. In addition, organizations such as National Institutes of Health (NIH) and National Science Foundation (NSF) raise funds for various proteomics projects. For instance, in September 2016, NIH announced to fund research on Proteomics, Immunoassay for TB Activation in HIV Patients. In 2015, National Cancer Institute offered grants for Clinical Proteomic Tumour Analysis Consortium (CPTAC) program. The governments of European countries also take various initiatives to promote proteomics research. The European Unions Seventh Framework Programme supports proteomics research by funding a group of proteomics researchers from European institutes for the next four years. In Australia, with assistance from government funding, the R&D expenditure on proteomics is expected to increase by 58% in 2016.
Europe Proteomics Market: Region-wise Outlook The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. In Europe, Germany leads the Proteomics market, followed by France and U.K. The market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness about Proteomics, financial strength to procure expensive tools, and favourable reimbursement policies.
Key Questions Answered What is the current and future Proteomics market outlook in Europe? What trends are affecting the Europe market? Market definition along with the identification of key drivers and restraints. Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a regional scale. What is the competitive landscape and market share of major players in the Proteomics market in Europe? What are the key market segments that currently occupy the highest market share? Which market segments are growing the fastest? What challenges are restraining the growth of the Proteomics market? How will emerging technologies answer these challenges? What is physician perception and market outlook of Proteomics?
Europe Proteomics Market: Key Players Some key players in this market are Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Waters Corporation.
Reasons to buy Europe Proteomics Market Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|